About Amulet capital partners
Amulet Capital Partners: Creating Long-Term Value in Healthcare
Amulet Capital Partners is a private equity investment firm that specializes in the healthcare sector. The company was founded in 2015 by a team of experienced healthcare investors and operators who recognized the need for a dedicated middle-market private equity firm focused on creating long-term value for market leaders in the healthcare industry.
The company's mission is to partner with exceptional management teams to build great companies that deliver superior returns to investors while improving patient outcomes and advancing the quality of care. Amulet Capital Partners invests primarily in companies with enterprise values between $50 million and $500 million, targeting opportunities across all segments of the healthcare industry, including pharmaceuticals, medical devices, diagnostics, services, and technology-enabled solutions.
Amulet Capital Partners' investment approach is based on deep industry knowledge, rigorous due diligence, and active portfolio management. The company's team has extensive experience investing across all stages of the healthcare lifecycle – from early-stage venture capital to growth equity to leveraged buyouts – as well as operating experience at leading healthcare companies.
The firm's investment philosophy centers around four key principles:
1. Focus on market leaders: Amulet Capital Partners seeks out companies that are leaders or emerging leaders within their respective markets. These companies typically have strong competitive positions, differentiated products or services, attractive growth prospects, and sustainable business models.
2. Partner with exceptional management teams: The firm believes that success in private equity investing depends largely on partnering with talented executives who have a clear vision for their businesses and a track record of execution. Amulet Capital Partners works closely with its portfolio company management teams to provide strategic guidance and operational support while empowering them to drive value creation initiatives.
3. Create long-term value: The firm takes a patient approach to investing by focusing on building sustainable businesses over time rather than seeking short-term gains through financial engineering or cost-cutting measures. This approach allows portfolio companies to invest in innovation, expand into new markets or product lines, improve operational efficiency or clinical outcomes while maintaining high standards of quality care delivery.
4. Align interests: Amulet Capital Partners aligns its interests closely with those of its limited partners (LPs) by co-investing alongside them in every transaction it undertakes. This ensures that LPs benefit directly from the success of each investment while also providing an additional layer of alignment between GP (general partner) and LP interests.
Since its inception five years ago, Amulet Capital Partners has built an impressive track record of successful investments across various sub-sectors within healthcare such as specialty pharmaceuticals (e.g., Avomeen Analytical Services), medical devices (e.g., Bioventus), diagnostic testing (e.g., Epiphany Dermatology), behavioral health services (e.g., BrightSpring Health Services), among others.
In addition to making direct investments into portfolio companies through traditional buyout transactions or growth capital infusions; Amulet also provides strategic advisory services such as M&A advisory work; helping clients identify potential acquisition targets; conducting due diligence assessments; negotiating deal terms & conditions; structuring financing arrangements etc..
Overall ,Amulet capital partners stands out among other PE firms because they are solely focused on creating long term value for market leaders within Healthcare sector .Their deep industry knowledge coupled with rigorous due diligence process enables them identify attractive opportunities which they can then leverage their expertise & resources towards driving significant improvements both operationally & clinically .Their commitment towards aligning interest between GP & LP ensures they remain committed towards delivering superior returns over time .